• Here’s Why Cancer Survivorship Becomes Lonely
  • Phase 3 Study of Prostvac in Castration-resistant Prostate Cancer Discontinued
  • INO-5150 Triggers Immune Responses, Delays Progression of Prostate Cancer That Returns, Trial Shows
  • Janssen Submits Supplemental New Drug Application for Zytiga to Treat Metastatic Prostate Cancer
  • Xtandi Seen to Delay Metastasis in Castration-resistant Prostate Cancer, Trial Shows
  • Myriad Genetics Marking Prostate Cancer Awareness Month with Hereditary Testing Outreach
  • 10 Ways to Take a Break from the Stress of Cancer
  • Favorable Interim Data Presented for Tyme’s SM-88 Phase 2 Trial for Prostate Cancer Patients
  • Hormone Depletion Activates Tumor Survival Process in Prostate Cancer, Study Shows
  • Two High-Risk Prostate Cancer Treatments Have Similar Benefits, Add-On Study Finds
  • Long-Term Data Further Confirm SpaceOAR Hydrogel Quality-of-Life Benefits
  • No, Prostate Cancer is Not the ‘Good Cancer’